APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lisdexamfetamine API

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Lisdexamfetamine API Industry Growth and Trends Forecast to 2032

28 December 202593 pages

Choose your research edition.

Industry ResearchLisdexamfetamine API Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Lisdexamfetamine API Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Lisdexamfetamine API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lisdexamfetamine API Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Lisdexamfetamine API Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Lisdexamfetamine API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Lisdexamfetamine API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Lisdexamfetamine API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lisdexamfetamine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lisdexamfetamine API include Yichang Humanwell Pharmaceutical, Sichuan Credit Chemwerth Pharmaceutical, Jiangsu Huataichenguang Pharmaceutical, China National Medicines Guorui Pharmaceutical, SynZeal Research, Fermion, Embio Limited and Benuvia, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Lisdexamfetamine API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Lisdexamfetamine API market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lisdexamfetamine API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lisdexamfetamine API.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Lisdexamfetamine API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Lisdexamfetamine API Market by Company

Yichang Humanwell Pharmaceutical

Sichuan Credit Chemwerth Pharmaceutical

Jiangsu Huataichenguang Pharmaceutical

China National Medicines Guorui Pharmaceutical

SynZeal Research

Fermion

Embio Limited

Benuvia

Lisdexamfetamine API Segment by Type

USP Grade

EP Grade

Other

Lisdexamfetamine API Segment by Application

Tablets

Oral Solution

Capsules

Lisdexamfetamine API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lisdexamfetamine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lisdexamfetamine API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lisdexamfetamine API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lisdexamfetamine API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Lisdexamfetamine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of USP Grade Table 2. Major Company of EP Grade Table 3. Major Company of Other Table 4. Global Lisdexamfetamine API Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Lisdexamfetamine API Sales by Type (2021-2026) & (t) Table 6. Global Lisdexamfetamine API Sales Market Share in Volume by Type (2021-2026) Table 7. Global Lisdexamfetamine API Sales by Type (2021-2026) & (US$ Million) Table 8. Global Lisdexamfetamine API Sales Market Share in Value by Type (2021-2026) Table 9. Global Lisdexamfetamine API Price by Type (2021-2026) & (USD/kg) Table 10. Global Lisdexamfetamine API Sales by Type (2027-2032) & (t) Table 11. Global Lisdexamfetamine API Sales Market Share in Volume by Type (2027-2032) Table 12. Global Lisdexamfetamine API Sales by Type (2027-2032) & (US$ Million) Table 13. Global Lisdexamfetamine API Sales Market Share in Value by Type (2027-2032) Table 14. Global Lisdexamfetamine API Price by Type (2027-2032) & (USD/kg) Table 15. North America Lisdexamfetamine API Sales by Type (2021-2026) & (t) Table 16. North America Lisdexamfetamine API Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Lisdexamfetamine API Sales by Type (2021-2026) & (t) Table 18. Europe Lisdexamfetamine API Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Lisdexamfetamine API Sales by Type (2021-2026) & (t) Table 20. Asia-Pacific Lisdexamfetamine API Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Lisdexamfetamine API Sales by Type (2021-2026) & (t) Table 22. Latin America Lisdexamfetamine API Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Lisdexamfetamine API Sales by Type (2021-2026) & (t) Table 24. Middle East and Africa Lisdexamfetamine API Sales by Type (2021-2026) & (US$ Million) Table 25. Lisdexamfetamine API Industry Trends Table 26. Lisdexamfetamine API Industry Drivers Table 27. Lisdexamfetamine API Industry Opportunities and Challenges Table 28. Lisdexamfetamine API Industry Restraints Table 29. Global Lisdexamfetamine API Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Lisdexamfetamine API Revenue Market Share by Company (2021-2026) Table 31. Global Lisdexamfetamine API Sales by Company (2021-2026) & (t) Table 32. Global Lisdexamfetamine API Sales Share by Company (2021-2026) Table 33. Global Lisdexamfetamine API Market Price by Company (2021-2026) & (USD/kg) Table 34. Global Lisdexamfetamine API Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Lisdexamfetamine API Major Company Production Sites and Headquarters Table 36. Global Lisdexamfetamine API Company, Product Type & Application Table 37. Global Lisdexamfetamine API Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Lisdexamfetamine API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Lisdexamfetamine API Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Lisdexamfetamine API Sales by Region (2021-2026) & (t) Table 42. Global Lisdexamfetamine API Sales Market Share in Volume by Region (2021-2026) Table 43. Global Lisdexamfetamine API Sales by Region (2021-2026) & (US$ Million) Table 44. Global Lisdexamfetamine API Sales Market Share in Value by Region (2021-2026) Table 45. Global Lisdexamfetamine API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 46. Global Lisdexamfetamine API Sales by Region (2027-2032) & (t) Table 47. Global Lisdexamfetamine API Sales Market Share in Volume by Region (2027-2032) Table 48. Global Lisdexamfetamine API Sales by Region (2027-2032) & (US$ Million) Table 49. Global Lisdexamfetamine API Sales Market Share in Value by Region (2027-2032) Table 50. Global Lisdexamfetamine API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2027-2032) Table 51. Global Lisdexamfetamine API Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Lisdexamfetamine API Sales by Application (2021-2026) & (t) Table 53. Global Lisdexamfetamine API Sales Market Share in Volume by Application (2021-2026) Table 54. Global Lisdexamfetamine API Sales by Application (2021-2026) & (US$ Million) Table 55. Global Lisdexamfetamine API Sales Market Share in Value by Application (2021-2026) Table 56. Global Lisdexamfetamine API Price by Application (2021-2026) & (USD/kg) Table 57. Global Lisdexamfetamine API Sales by Application (2027-2032) & (t) Table 58. Global Lisdexamfetamine API Sales Market Share in Volume by Application (2027-2032) Table 59. Global Lisdexamfetamine API Sales by Application (2027-2032) & (US$ Million) Table 60. Global Lisdexamfetamine API Sales Market Share in Value by Application (2027-2032) Table 61. Global Lisdexamfetamine API Price by Application (2027-2032) & (USD/kg) Table 62. North America Lisdexamfetamine API Sales by Application (2021-2026) & (t) Table 63. North America Lisdexamfetamine API Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Lisdexamfetamine API Sales by Application (2021-2026) & (t) Table 65. Europe Lisdexamfetamine API Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Lisdexamfetamine API Sales by Application (2021-2026) & (t) Table 67. Asia-Pacific Lisdexamfetamine API Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Lisdexamfetamine API Sales by Application (2021-2026) & (t) Table 69. Latin America Lisdexamfetamine API Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Lisdexamfetamine API Sales by Application (2021-2026) & (t) Table 71. Middle East and Africa Lisdexamfetamine API Sales by Application (2021-2026) & (US$ Million) Table 72. Yichang Humanwell Pharmaceutical Company Information Table 73. Yichang Humanwell Pharmaceutical Business Overview Table 74. Yichang Humanwell Pharmaceutical Lisdexamfetamine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 75. Yichang Humanwell Pharmaceutical Lisdexamfetamine API Product Portfolio Table 76. Yichang Humanwell Pharmaceutical Recent Development Table 77. Sichuan Credit Chemwerth Pharmaceutical Company Information Table 78. Sichuan Credit Chemwerth Pharmaceutical Business Overview Table 79. Sichuan Credit Chemwerth Pharmaceutical Lisdexamfetamine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 80. Sichuan Credit Chemwerth Pharmaceutical Lisdexamfetamine API Product Portfolio Table 81. Sichuan Credit Chemwerth Pharmaceutical Recent Development Table 82. Jiangsu Huataichenguang Pharmaceutical Company Information Table 83. Jiangsu Huataichenguang Pharmaceutical Business Overview Table 84. Jiangsu Huataichenguang Pharmaceutical Lisdexamfetamine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 85. Jiangsu Huataichenguang Pharmaceutical Lisdexamfetamine API Product Portfolio Table 86. Jiangsu Huataichenguang Pharmaceutical Recent Development Table 87. China National Medicines Guorui Pharmaceutical Company Information Table 88. China National Medicines Guorui Pharmaceutical Business Overview Table 89. China National Medicines Guorui Pharmaceutical Lisdexamfetamine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 90. China National Medicines Guorui Pharmaceutical Lisdexamfetamine API Product Portfolio Table 91. China National Medicines Guorui Pharmaceutical Recent Development Table 92. SynZeal Research Company Information Table 93. SynZeal Research Business Overview Table 94. SynZeal Research Lisdexamfetamine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 95. SynZeal Research Lisdexamfetamine API Product Portfolio Table 96. SynZeal Research Recent Development Table 97. Fermion Company Information Table 98. Fermion Business Overview Table 99. Fermion Lisdexamfetamine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 100. Fermion Lisdexamfetamine API Product Portfolio Table 101. Fermion Recent Development Table 102. Embio Limited Company Information Table 103. Embio Limited Business Overview Table 104. Embio Limited Lisdexamfetamine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 105. Embio Limited Lisdexamfetamine API Product Portfolio Table 106. Embio Limited Recent Development Table 107. Benuvia Company Information Table 108. Benuvia Business Overview Table 109. Benuvia Lisdexamfetamine API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 110. Benuvia Lisdexamfetamine API Product Portfolio Table 111. Benuvia Recent Development Table 112. North America Lisdexamfetamine API Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 113. North America Lisdexamfetamine API Sales by Country (2021-2026) & (t) Table 114. North America Lisdexamfetamine API Sales Market Share by Country (2021-2026) Table 115. North America Lisdexamfetamine API Sales Forecast by Country (2027-2032) & (t) Table 116. North America Lisdexamfetamine API Sales Market Share Forecast by Country (2027-2032) Table 117. North America Lisdexamfetamine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Lisdexamfetamine API Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Lisdexamfetamine API Market Share by Country (2021-2026) Table 120. North America Lisdexamfetamine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Lisdexamfetamine API Market Share Forecast by Country (2027-2032) Table 122. Europe Lisdexamfetamine API Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 123. Europe Lisdexamfetamine API Sales by Country (2021-2026) & (t) Table 124. Europe Lisdexamfetamine API Sales Market Share by Country (2021-2026) Table 125. Europe Lisdexamfetamine API Sales Forecast by Country (2027-2032) & (t) Table 126. Europe Lisdexamfetamine API Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Lisdexamfetamine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Lisdexamfetamine API Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Lisdexamfetamine API Market Share by Country (2021-2026) Table 130. Europe Lisdexamfetamine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Lisdexamfetamine API Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Lisdexamfetamine API Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Lisdexamfetamine API Sales by Country (2021-2026) & (t) Table 134. Asia-Pacific Lisdexamfetamine API Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Lisdexamfetamine API Sales Forecast by Country (2027-2032) & (t) Table 136. Asia-Pacific Lisdexamfetamine API Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Lisdexamfetamine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Lisdexamfetamine API Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Lisdexamfetamine API Market Share by Country (2021-2026) Table 140. Asia-Pacific Lisdexamfetamine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Lisdexamfetamine API Market Share Forecast by Country (2027-2032) Table 142. Latin America Lisdexamfetamine API Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 143. Latin America Lisdexamfetamine API Sales by Country (2021-2026) & (t) Table 144. Latin America Lisdexamfetamine API Sales Market Share by Country (2021-2026) Table 145. Latin America Lisdexamfetamine API Sales Forecast by Country (2027-2032) & (t) Table 146. Latin America Lisdexamfetamine API Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Lisdexamfetamine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Lisdexamfetamine API Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Lisdexamfetamine API Market Share by Country (2021-2026) Table 150. Latin America Lisdexamfetamine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Lisdexamfetamine API Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Lisdexamfetamine API Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Lisdexamfetamine API Sales by Country (2021-2026) & (t) Table 154. Middle East and Africa Lisdexamfetamine API Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Lisdexamfetamine API Sales Forecast by Country (2027-2032) & (t) Table 156. Middle East and Africa Lisdexamfetamine API Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Lisdexamfetamine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Lisdexamfetamine API Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Lisdexamfetamine API Market Share by Country (2021-2026) Table 160. Middle East and Africa Lisdexamfetamine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Lisdexamfetamine API Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Lisdexamfetamine API Distributors List Table 165. Lisdexamfetamine API Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Lisdexamfetamine API Image Figure 2. Global Lisdexamfetamine API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lisdexamfetamine API Market Size (2021-2032) & (US$ Million) Figure 4. Global Lisdexamfetamine API Sales (2021-2032) & (t) Figure 5. USP Grade Image Figure 6. Global USP Grade Sales YoY Growth (2021-2032) & (t) Figure 7. EP Grade Image Figure 8. Global EP Grade Sales YoY Growth (2021-2032) & (t) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (t) Figure 11. Global Lisdexamfetamine API Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Lisdexamfetamine API Market Share by Type 2025 VS 2032 Figure 13. North America Lisdexamfetamine API Sales Market Share in Volume by Type in 2025 Figure 14. North America Lisdexamfetamine API Sales Market Share in Value by Type in 2025 Figure 15. Europe Lisdexamfetamine API Sales Market Share in Volume by Type in 2025 Figure 16. Europe Lisdexamfetamine API Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Lisdexamfetamine API Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Lisdexamfetamine API Sales Market Share in Value by Type in 2025 Figure 19. Latin America Lisdexamfetamine API Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Lisdexamfetamine API Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Lisdexamfetamine API Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Lisdexamfetamine API Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Lisdexamfetamine API Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Tablets Image Figure 26. Global Tablets Sales YoY Growth (2021-2032) & (t) Figure 27. Oral Solution Image Figure 28. Global Oral Solution Sales YoY Growth (2021-2032) & (t) Figure 29. Capsules Image Figure 30. Global Capsules Sales YoY Growth (2021-2032) & (t) Figure 31. Global Lisdexamfetamine API Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Lisdexamfetamine API Market Share by Application 2025 VS 2032 Figure 33. North America Lisdexamfetamine API Sales Market Share in Volume by Application in 2025 Figure 34. North America Lisdexamfetamine API Sales Market Share in Value by Application in 2025 Figure 35. Europe Lisdexamfetamine API Sales Market Share in Volume by Application in 2025 Figure 36. Europe Lisdexamfetamine API Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Lisdexamfetamine API Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Lisdexamfetamine API Sales Market Share in Value by Application in 2025 Figure 39. Latin America Lisdexamfetamine API Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Lisdexamfetamine API Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Lisdexamfetamine API Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Lisdexamfetamine API Sales Market Share in Value by Application in 2025 Figure 43. North America Lisdexamfetamine API Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 44. North America Lisdexamfetamine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Lisdexamfetamine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Lisdexamfetamine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Lisdexamfetamine API Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 48. Europe Lisdexamfetamine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Lisdexamfetamine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Lisdexamfetamine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Lisdexamfetamine API Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 52. Asia-Pacific Lisdexamfetamine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Lisdexamfetamine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Lisdexamfetamine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Lisdexamfetamine API Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 56. Latin America Lisdexamfetamine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Lisdexamfetamine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Lisdexamfetamine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Lisdexamfetamine API Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 60. Middle East and Africa Lisdexamfetamine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Lisdexamfetamine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Lisdexamfetamine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Lisdexamfetamine API Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Lisdexamfetamine API Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • USP Grade
  • EP Grade
  • Other
Applications
  • Tablets
  • Oral Solution
  • Capsules
Companies covered
  • Yichang Humanwell Pharmaceutical
  • Sichuan Credit Chemwerth Pharmaceutical
  • Jiangsu Huataichenguang Pharmaceutical
  • China National Medicines Guorui Pharmaceutical
  • SynZeal Research
  • Fermion
  • Embio Limited
  • Benuvia

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lisdexamfetamine API Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Lisdexamfetamine API Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Lisdexamfetamine API Market by Type
  6. 1.3.1 USP Grade
  7. 1.3.2 EP Grade
  8. 1.3.3 Other
  9. 1.4 Global Lisdexamfetamine API Market Size by Type
  10. 1.4.1 Global Lisdexamfetamine API Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Lisdexamfetamine API Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Lisdexamfetamine API Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Lisdexamfetamine API Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Lisdexamfetamine API Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Lisdexamfetamine API Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Lisdexamfetamine API Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Lisdexamfetamine API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Lisdexamfetamine API Industry Trends
  2. 2.2 Lisdexamfetamine API Industry Drivers
  3. 2.3 Lisdexamfetamine API Industry Opportunities and Challenges
  4. 2.4 Lisdexamfetamine API Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Lisdexamfetamine API Revenue (2021-2026)
  2. 3.2 Global Top Players by Lisdexamfetamine API Sales (2021-2026)
  3. 3.3 Global Top Players by Lisdexamfetamine API Price (2021-2026)
  4. 3.4 Global Lisdexamfetamine API Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lisdexamfetamine API Major Company Production Sites & Headquarters
  6. 3.6 Global Lisdexamfetamine API Company, Product Type & Application
  7. 3.7 Global Lisdexamfetamine API Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lisdexamfetamine API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lisdexamfetamine API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lisdexamfetamine API Tier 1, Tier 2, and Tier 3
4 Lisdexamfetamine API Regional Status and Outlook
  1. 4.1 Global Lisdexamfetamine API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Lisdexamfetamine API Historic Market Size by Region
  3. 4.2.1 Global Lisdexamfetamine API Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Lisdexamfetamine API Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Lisdexamfetamine API Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Lisdexamfetamine API Forecasted Market Size by Region
  7. 4.3.1 Global Lisdexamfetamine API Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Lisdexamfetamine API Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Lisdexamfetamine API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Lisdexamfetamine API by Application
  1. 5.1 Lisdexamfetamine API Market by Application
  2. 5.1.1 Tablets
  3. 5.1.2 Oral Solution
  4. 5.1.3 Capsules
  5. 5.2 Global Lisdexamfetamine API Market Size by Application
  6. 5.2.1 Global Lisdexamfetamine API Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Lisdexamfetamine API Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Lisdexamfetamine API Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Lisdexamfetamine API Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Lisdexamfetamine API Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Lisdexamfetamine API Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Lisdexamfetamine API Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Lisdexamfetamine API Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yichang Humanwell Pharmaceutical
  2. 6.1.1 Yichang Humanwell Pharmaceutical Company Information
  3. 6.1.2 Yichang Humanwell Pharmaceutical Business Overview
  4. 6.1.3 Yichang Humanwell Pharmaceutical Lisdexamfetamine API Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yichang Humanwell Pharmaceutical Lisdexamfetamine API Product Portfolio
  6. 6.1.5 Yichang Humanwell Pharmaceutical Recent Developments
  7. 6.2 Sichuan Credit Chemwerth Pharmaceutical
  8. 6.2.1 Sichuan Credit Chemwerth Pharmaceutical Company Information
  9. 6.2.2 Sichuan Credit Chemwerth Pharmaceutical Business Overview
  10. 6.2.3 Sichuan Credit Chemwerth Pharmaceutical Lisdexamfetamine API Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sichuan Credit Chemwerth Pharmaceutical Lisdexamfetamine API Product Portfolio
  12. 6.2.5 Sichuan Credit Chemwerth Pharmaceutical Recent Developments
  13. 6.3 Jiangsu Huataichenguang Pharmaceutical
  14. 6.3.1 Jiangsu Huataichenguang Pharmaceutical Company Information
  15. 6.3.2 Jiangsu Huataichenguang Pharmaceutical Business Overview
  16. 6.3.3 Jiangsu Huataichenguang Pharmaceutical Lisdexamfetamine API Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jiangsu Huataichenguang Pharmaceutical Lisdexamfetamine API Product Portfolio
  18. 6.3.5 Jiangsu Huataichenguang Pharmaceutical Recent Developments
  19. 6.4 China National Medicines Guorui Pharmaceutical
  20. 6.4.1 China National Medicines Guorui Pharmaceutical Company Information
  21. 6.4.2 China National Medicines Guorui Pharmaceutical Business Overview
  22. 6.4.3 China National Medicines Guorui Pharmaceutical Lisdexamfetamine API Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 China National Medicines Guorui Pharmaceutical Lisdexamfetamine API Product Portfolio
  24. 6.4.5 China National Medicines Guorui Pharmaceutical Recent Developments
  25. 6.5 SynZeal Research
  26. 6.5.1 SynZeal Research Company Information
  27. 6.5.2 SynZeal Research Business Overview
  28. 6.5.3 SynZeal Research Lisdexamfetamine API Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 SynZeal Research Lisdexamfetamine API Product Portfolio
  30. 6.5.5 SynZeal Research Recent Developments
  31. 6.6 Fermion
  32. 6.6.1 Fermion Company Information
  33. 6.6.2 Fermion Business Overview
  34. 6.6.3 Fermion Lisdexamfetamine API Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Fermion Lisdexamfetamine API Product Portfolio
  36. 6.6.5 Fermion Recent Developments
  37. 6.7 Embio Limited
  38. 6.7.1 Embio Limited Company Information
  39. 6.7.2 Embio Limited Business Overview
  40. 6.7.3 Embio Limited Lisdexamfetamine API Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Embio Limited Lisdexamfetamine API Product Portfolio
  42. 6.7.5 Embio Limited Recent Developments
  43. 6.8 Benuvia
  44. 6.8.1 Benuvia Company Information
  45. 6.8.2 Benuvia Business Overview
  46. 6.8.3 Benuvia Lisdexamfetamine API Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Benuvia Lisdexamfetamine API Product Portfolio
  48. 6.8.5 Benuvia Recent Developments
7 North America by Country
  1. 7.1 North America Lisdexamfetamine API Sales by Country
  2. 7.1.1 North America Lisdexamfetamine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Lisdexamfetamine API Sales by Country (2021-2026)
  4. 7.1.3 North America Lisdexamfetamine API Sales Forecast by Country (2027-2032)
  5. 7.2 North America Lisdexamfetamine API Market Size by Country
  6. 7.2.1 North America Lisdexamfetamine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Lisdexamfetamine API Market Size by Country (2021-2026)
  8. 7.2.3 North America Lisdexamfetamine API Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Lisdexamfetamine API Sales by Country
  2. 8.1.1 Europe Lisdexamfetamine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Lisdexamfetamine API Sales by Country (2021-2026)
  4. 8.1.3 Europe Lisdexamfetamine API Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Lisdexamfetamine API Market Size by Country
  6. 8.2.1 Europe Lisdexamfetamine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Lisdexamfetamine API Market Size by Country (2021-2026)
  8. 8.2.3 Europe Lisdexamfetamine API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Lisdexamfetamine API Sales by Country
  2. 9.1.1 Asia-Pacific Lisdexamfetamine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Lisdexamfetamine API Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Lisdexamfetamine API Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Lisdexamfetamine API Market Size by Country
  6. 9.2.1 Asia-Pacific Lisdexamfetamine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Lisdexamfetamine API Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Lisdexamfetamine API Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Lisdexamfetamine API Sales by Country
  2. 10.1.1 South America Lisdexamfetamine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Lisdexamfetamine API Sales by Country (2021-2026)
  4. 10.1.3 South America Lisdexamfetamine API Sales Forecast by Country (2027-2032)
  5. 10.2 South America Lisdexamfetamine API Market Size by Country
  6. 10.2.1 South America Lisdexamfetamine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Lisdexamfetamine API Market Size by Country (2021-2026)
  8. 10.2.3 South America Lisdexamfetamine API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Lisdexamfetamine API Sales by Country
  2. 11.1.1 Middle East and Africa Lisdexamfetamine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Lisdexamfetamine API Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Lisdexamfetamine API Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Lisdexamfetamine API Market Size by Country
  6. 11.2.1 Middle East and Africa Lisdexamfetamine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Lisdexamfetamine API Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Lisdexamfetamine API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Lisdexamfetamine API Value Chain Analysis
  2. 12.1.1 Lisdexamfetamine API Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Lisdexamfetamine API Production Mode & Process
  7. 12.2 Lisdexamfetamine API Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Lisdexamfetamine API Distributors
  10. 12.2.3 Lisdexamfetamine API Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst